Survival and fracture risk with radium-223 therapy in metastatic castrate-resistant prostate cancer (mCRPC): A real-world analysis.

Autor: Zhang, Hanbo, Graham, Jeffrey, Czaykowski, Piotr, Gingerich, Joel Roger, Bybel, Bohdan, Dawe, David E
Zdroj: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p50-50, 235p
Databáze: Supplemental Index